The ADP-Ribosylation Factor 4d Restricts Regulatory T-Cell Induction via Control of IL-2 Availability

Cells. 2022 Aug 25;11(17):2639. doi: 10.3390/cells11172639.

Abstract

Interleukin-2 is central to the induction and maintenance of both natural (nTreg) and induced Foxp3-expressing regulatory T cells (iTreg). Thus, signals that modulate IL-2 availability may, in turn, also influence Treg homeostasis. Using global knockout and cell-specific knockout mouse models, we evaluated the role of the small GTPase ADP-ribosylation factor 4d (Arl4d) in regulatory T-cell biology. We show that the expression of Arl4d in T cells restricts both IL-2 production and responsiveness to IL-2, as measured by the phosphorylation of STAT5. Arl4d-deficient CD4 T cells converted more efficiently into Foxp3+ iTreg in vitro in the presence of αCD3ε and TGFβ, which was associated with their enhanced IL-2 secretion. As such, Arl4d-/- CD4 T cells induced significantly less colonic inflammation and lymphocytic infiltration in a model of transfer colitis. Thus, our data reveal a negative regulatory role for Arl4d in CD4 T-cell biology, limiting iTreg conversion via the restriction of IL-2 production, leading to reduced induction of Treg from conventional CD4 T cells.

Keywords: Arl4d; Foxp3; immune regulation; interleukin 2; pSTAT5; regulatory T cell.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADP-Ribosylation Factors / metabolism
  • Animals
  • Forkhead Transcription Factors / metabolism
  • Interleukin-2* / metabolism
  • Mice
  • Mice, Knockout
  • T-Lymphocytes, Regulatory* / metabolism
  • Transforming Growth Factor beta / metabolism

Substances

  • Forkhead Transcription Factors
  • Interleukin-2
  • Transforming Growth Factor beta
  • ADP-Ribosylation Factors
  • Arl4D protein, mouse

Grants and funding

This research was funded in part by the Werner-Otto Stiftung (4/93), the Erich und Gertrud Roggenbuck Stiftung (1562/105), and the Wilhelm-Sander Stiftung (2016.022.1).